Deferiprone versus desferrioxamine in thalassaemia, and T2* validation and utility.
Brittenham
G M
GM
Nathan
D G
DG
Olivieri
N F
NF
Pippard
M J
MJ
Weatherall
D J
DJ
D009202:Cardiomyopathies / Q000401:mortality; D000077543:Deferiprone; D003676:Deferoxamine / Q000627:therapeutic use*; D006801:Humans; D007502:Iron Chelating Agents / Q000627:therapeutic use*; D011728:Pyridones / Q000627:therapeutic use*; D015203:Reproducibility of Results; D017086:beta-Thalassemia / Q000188:drug therapy* / Q000401:mortality
D007502:Iron Chelating Agents; D011728:Pyridones; D000077543:Deferiprone; D003676:Deferoxamine